Company Kindred Biosciences, Inc.

Equities

KIN

US4945771099

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Bio Therapeutic Drugs

Inactive Instrument

Kindred Biosciences, Inc. is a United States-based company. The Company is a veterinary biopharmaceutical company developing medicines for cats, dogs and horses. Its product is Zimeta (dipyrone injection). The Company is engaged in revolutionizing veterinary therapeutic biologics, such as monoclonal antibodies and recombinant proteins.

Number of employees: 63

Managers	Title	Age	Since
Jay Peterson PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
David Pugh BRD	Director/Board Member	-	21-08-26
Kathleen St. Louis BRD	Director/Board Member	-	02-08-26
Jinee Majors BRD	Director/Board Member	-	21-08-26

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	45,462,318	36,805,982 ( 80.96 %)	0	80.96 %

Kindred Biosciences, Inc.

1555 Bayshore Highway Suite 200

94010, Burlingame

+650 701 7901

http://www.kindredbio.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.26%	104B
REGENERON PHARMACEUTICALS, INC.	+1.41%	97.42B
ARGENX SE	+0.79%	22.2B
BIONTECH SE	-17.84%	21.23B
GENMAB A/S	-11.11%	18.33B
WUXI APPTEC CO., LTD.	-42.83%	16.35B
BEIGENE, LTD.	-17.63%	15.06B
NEUROCRINE BIOSCIENCES, INC.	+4.55%	13.98B
SAREPTA THERAPEUTICS, INC.	+32.11%	11.66B

Bio Therapeutic Drugs